Insight Molecular Diagnostics logo

Insight Molecular Diagnostics Share Price Today (NASDAQ: IMDX)

Insight Molecular Diagnostics share price is $3.5 & ₹303.00 as on 22 Jun 2025, 2.30 'hrs' IST

$3.5

▲

0.34

(10.76%)

Market is closed - opens 7 PM, 23 Jun 2025

View live Insight Molecular Diagnostics share price in Dollar and Rupees. Guide to invest in Insight Molecular Diagnostics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Insight Molecular Diagnostics, along with analyst recommendations, forecasts, and comprehensive financials.

Insight Molecular Diagnostics (IMDX) Key Statistics

in dollars & INR

Previous Close
$3.16
Open
$2.94
Today's High
$3.71
Today's Low
$2.94
Revenue TTM
$0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Insight Molecular Diagnostics Stock (IMDX) from India?

It is very easy for Indian residents to invest directly in Insight Molecular Diagnostics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Insight Molecular Diagnostics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Insight Molecular Diagnostics or IMDX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Insight Molecular Diagnostics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Insight Molecular Diagnostics shares which would translate to 0.247 fractional shares of Insight Molecular Diagnostics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Insight Molecular Diagnostics, in just a few clicks!

Returns in Insight Molecular Diagnostics (IMDX) for Indian investors in Rupees

The Insight Molecular Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Insight Molecular Diagnostics investment value today

Current value as on today

₹1,27,280

Returns

₹27,280

(+27.28%)

Returns from Insight Molecular Diagnostics Stock

₹23,675 (+23.67%)

Dollar Returns*

₹3,605 (+3.6%)

Indian investors sentiment towards Insight Molecular Diagnostics (IMDX)

967%

Period: May 21, 2025 to Jun 20, 2025. Change in 30 Days versus previous period

Search interest for Insight Molecular Diagnostics Stock from India on INDmoney has increased by 967% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Insight Molecular Diagnostics

Rating
Trend

Insights on Insight Molecular Diagnostics Stock (Ticker Symbol: IMDX)

  • Price Movement

    In the last 7 days, IMDX stock has moved up by 19.2%

Insight Molecular Diagnostics Technicals Summary

Sell

Neutral

Buy

Insight Molecular Diagnostics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Insight Molecular Diagnostics (IMDX) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Insight Molecular Diagnostics Inc logo
Insight Molecular Diagnostics Inc
2.93%
44.29%
11.66%
-83.87%
-95.09%

About Insight Molecular Diagnostics

Oncocyte Corporation is a precision diagnostics company. The Company is engaged in the development of Oncocytes tests and the acquisition of proprietary molecular technologies in the fields of oncology and transplantation. The Company’s products include DetermaIO, VitaGraft, DetermaCNI and GraftAssure. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. DetermaIO measures the expression level of 27 selected genes, which are interpreted through the use of a proprietary algorithm (patent pending) which computes a quantitative score (IO Score) that incorporates information from the immune inflammatory infiltrates within and around the tumor. Its pipeline test, DetermaCNI, is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. VitaGraft is a blood-based solid organ transplantation monitoring test. GraftAssure is a research use only blood-based solid organ transplantation monitoring test.
Organization
Insight Molecular Diagnostics
CEO
Dr. Michael D. West Ph.D.
Industry
Miscellaneous

Management People of Insight Molecular Diagnostics

NameTitle
Mr. Joshua Riggs
President, CEO & Director
Ms. Andrea Susan James
Chief Financial Officer
Mr. James Liu
VP of Accounting, Treasurer, Controller & Principal Accounting Officer
Dr. Ekkehard Schutz M.D., Ph.D.
Chief Science Officer
Mr. Yuh-Min Chiang Ph.D.
Chief Technology Officer
Mr. Peter Hong
VP, General Counsel & Secretary
Ms. Sandra O'Donald
Senior Vice President of Business Operations
Dr. Paul R. Billings FACP, M.D.
Consulting Chief Medical Officer
Dr. Michael D. West Ph.D.
Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc.
Ms. Gabrielle Woody
Sr. Executive Assistant

Important FAQs about investing in IMDX Stock from India :

Can Indians buy Insight Molecular Diagnostics shares?

Yes, Indians can invest in the Insight Molecular Diagnostics (IMDX) from India.

With INDmoney, you can buy Insight Molecular Diagnostics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Insight Molecular Diagnostics at zero transaction cost.

How can I buy Insight Molecular Diagnostics shares from India?

It is very easy to buy Insight Molecular Diagnostics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Insight Molecular Diagnostics (IMDX) be purchased?

Yes, you can buy fractional shares of Insight Molecular Diagnostics with INDmoney app.

What are the documents required to start investing in Insight Molecular Diagnostics stocks?

To start investing in Insight Molecular Diagnostics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Insight Molecular Diagnostics share price today?

Insight Molecular Diagnostics share price today stands at $3.50, Open: $2.94 ; Previous Close: $3.16 ; High: {{1_rba_end}} ; Low: {{1_rba_st}} ; 52 Week High: {{rba_end}} ; 52 Week Low: {{rba_st}}.

The stock opens at $2.94, after a closing price of $3.16. The stock reached a daily high of {{1_rba_end}} and a low of {{1_rba_st}}, with a 52-week high of {{rba_end}} and a 52-week low of {{rba_st}}.

What are today’s High and Low prices of Insight Molecular Diagnostics Stock (IMDX)?

Today’s highest price of Insight Molecular Diagnostics (IMDX) is {{1_rba_end}}.

Today’s lowest price of Insight Molecular Diagnostics (IMDX) is {{1_rba_st}}.

What is the 52 Week High and Low Range of Insight Molecular Diagnostics Stock (IMDX)?

  • 52 Week High

    {{rba_end}}

  • 52 Week Low

    {{rba_st}}

What are the historical returns of Insight Molecular Diagnostics (IMDX)?

  • 1 Month Returns

    2.93%

  • 3 Months Returns

    44.29%

  • 1 Year Returns

    11.66%

  • 5 Years Returns

    -95.09%

Who is the Chief Executive Officer (CEO) of Insight Molecular Diagnostics ?

Dr. Michael D. West Ph.D. is the current Chief Executive Officer (CEO) of Insight Molecular Diagnostics.